Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seetharaman Balasenthil

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Scientific Reports|November 14, 2022
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancerUyen Q Le, Nanyue Chen, Seetharaman Balasenthil, et al.
Cancer Research|August 3, 2007
Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomasRozita Bagheri-Yarmand, Seetharaman Balasenthil, Anupama E Gururaj, et al.
Cancer Discovery|July 11, 2013
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionNanyue Chen, Seetharaman Balasenthil, Jacquelyn Reuther, et al.
Gastro Hep Advances|November 12, 2024
Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic SamplesWarapen Treekitkarnmongkol, Jianliang Dai, Suyu Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase 2 blinded biomarker validation and panel discovery studyAnn L Oberg, William R Bamlet, Grant Izmirlian, et al.
Plos One|October 3, 2015
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma SpecimensBrian B Haab, Ying Huang, Seetharaman Balasenthil, et al.
Plos Medicine|June 19, 2009
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancerSteven T Lott, Nanyue Chen, Dawn S Chandler, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Scientific Reports|November 14, 2022
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancerUyen Q Le, Nanyue Chen, Seetharaman Balasenthil, et al.
Cancer Research|August 3, 2007
Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomasRozita Bagheri-Yarmand, Seetharaman Balasenthil, Anupama E Gururaj, et al.
Cancer Discovery|July 11, 2013
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionNanyue Chen, Seetharaman Balasenthil, Jacquelyn Reuther, et al.
Gastro Hep Advances|November 12, 2024
Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic SamplesWarapen Treekitkarnmongkol, Jianliang Dai, Suyu Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase 2 blinded biomarker validation and panel discovery studyAnn L Oberg, William R Bamlet, Grant Izmirlian, et al.
Plos One|October 3, 2015
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma SpecimensBrian B Haab, Ying Huang, Seetharaman Balasenthil, et al.
Plos Medicine|June 19, 2009
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancerSteven T Lott, Nanyue Chen, Dawn S Chandler, et al.
Pageof 4